The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-β plaque and glial pathology in a mouse model of Alzheimer's disease.

Caitriona M Long-Smith, Sean Manning, PL McClean, Meghan F Coakley, Domhnall J O'Halloran, Christian Holscher, Cora O'Neill

Research output: Contribution to journalArticlepeer-review

105 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-β plaque and glial pathology in a mouse model of Alzheimer's disease.'. Together they form a unique fingerprint.

Medicine & Life Sciences